Additionally, the phosphorylation of Tyr261 in PPP2R1A enhances the activity of PP2A, leading to the dephosphorylation of IMPDH2, thereby promoting S-phase progression and tumor growth downstream of the FGFR signaling pathway (Zhou et al. 2025). The gene discussed is PTPA; the disease is neoplasm.